Inkef Capital

Inkef Capital, founded in 2010 and based in Amsterdam, is a prominent early-stage venture capital firm focused on technology and healthcare sectors. They prioritize investments in therapeutics, digital health, medical devices, and areas like the Future of Commerce, Future of Work, Data & AI Stack, Fintech, and DeepTech. Inkef is known for their patient, long-term approach, supporting companies from seed to Series A rounds and beyond. Inkef’s portfolio includes notable investments in companies such as GitLab, Onward Medical, and Aidence, reflecting their commitment to impactful, innovative solutions. They have a track record of successful exits, further emphasizing their strategic investment prowess. The firm’s investment strategy revolves around identifying mission-driven entrepreneurs addressing significant global challenges with unique solutions. Inkef prefers companies with ambitious teams ready to scale globally. They value deep, hands-on collaboration, aiming to build lasting companies rather than quick exits​. Key team members include Managing Partner Reitze Douma, Senior Partner Frank Lansink, and Partners like Thijs Cohen Tervaert and Simone Botti. Their diverse and experienced team is dedicated to fostering innovation and supporting founders through various stages of growth. For startups looking to engage with Inkef Capital, demonstrating a clear, innovative vision and readiness for global scale are crucial. They are approachable through their structured process and value long-term strategic partnerships aimed at creating substantial, sustainable impact​.